Drug companies' lobbying of ministers has little effect on NICE

BMJ 2006; 333 doi: (Published 05 October 2006) Cite this as: BMJ 2006;333:719
  1. Andrew Jack, pharmaceutical correspondent
  1. Financial Times

    Aggressive lobbying of government ministers by drug companies seeking to overturn the judgments of the body that advises on the use of treatments by the NHS in England and Wales has had little effect on its decisions.

    Minutes of civil service meetings obtained by the Guardian (Sep 28, p 1) under freedom of information laws show that during the eight months to May this year senior executives from …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription